• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于转移性卵巢癌自动图像分割和治疗反应评估的多任务深度学习

Multi-task deep learning for automatic image segmentation and treatment response assessment in metastatic ovarian cancer.

作者信息

Drury Bevis, Machado Inês P, Gao Zeyu, Buddenkotte Thomas, Mahani Golnar, Funingana Gabriel, Reinius Marika, McCague Cathal, Woitek Ramona, Sahdev Anju, Sala Evis, Brenton James D, Crispin-Ortuzar Mireia

机构信息

Department of Physics, University of Cambridge, Cambridge, United Kingdom.

Department of Oncology, University of Cambridge, Cambridge, United Kingdom.

出版信息

Int J Comput Assist Radiol Surg. 2025 Sep 3. doi: 10.1007/s11548-025-03484-0.

DOI:10.1007/s11548-025-03484-0
PMID:40900399
Abstract

PURPOSE

: High-grade serous ovarian carcinoma (HGSOC) is characterised by significant spatial and temporal heterogeneity, often presenting at an advanced metastatic stage. One of the most common treatment approaches involves neoadjuvant chemotherapy (NACT), followed by surgery. However, the multi-scale complexity of HGSOC poses a major challenge in evaluating response to NACT.

METHODS

: Here, we present a multi-task deep learning approach that facilitates simultaneous segmentation of pelvic/ovarian and omental lesions in contrast-enhanced computerised tomography (CE-CT) scans, as well as treatment response assessment in metastatic ovarian cancer. The model combines multi-scale feature representations from two identical U-Net architectures, allowing for an in-depth comparison of CE-CT scans acquired before and after treatment. The network was trained using 198 CE-CT images of 99 ovarian cancer patients for predicting segmentation masks and evaluating treatment response.

RESULTS

: It achieves an AUC of 0.78 (95% CI [0.70-0.91]) in an independent cohort of 98 scans of 49 ovarian cancer patients from a different institution. In addition to the classification performance, the segmentation Dice scores are only slightly lower than the current state-of-the-art for HGSOC segmentation.

CONCLUSION

: This work is the first to demonstrate the feasibility of a multi-task deep learning approach in assessing chemotherapy-induced tumour changes across the main disease burden of patients with complex multi-site HGSOC, which could be used for treatment response evaluation and disease monitoring.

摘要

目的

高级别浆液性卵巢癌(HGSOC)具有显著的空间和时间异质性,常于晚期转移阶段出现。最常见的治疗方法之一是新辅助化疗(NACT),随后进行手术。然而,HGSOC的多尺度复杂性给评估对NACT的反应带来了重大挑战。

方法

在此,我们提出一种多任务深度学习方法,该方法有助于在对比增强计算机断层扫描(CE-CT)扫描中同时分割盆腔/卵巢和网膜病变,以及评估转移性卵巢癌的治疗反应。该模型结合了来自两个相同U-Net架构的多尺度特征表示,从而能够对治疗前后获取的CE-CT扫描进行深入比较。使用99例卵巢癌患者的198张CE-CT图像对网络进行训练,以预测分割掩码并评估治疗反应。

结果

在来自不同机构的49例卵巢癌患者的98次扫描的独立队列中,其AUC为0.78(95%CI[0.70-0.91])。除分类性能外,分割Dice分数仅略低于目前HGSOC分割的最先进水平。

结论

这项工作首次证明了多任务深度学习方法在评估复杂多部位HGSOC患者主要疾病负担的化疗诱导肿瘤变化方面的可行性,可用于治疗反应评估和疾病监测。

相似文献

1
Multi-task deep learning for automatic image segmentation and treatment response assessment in metastatic ovarian cancer.用于转移性卵巢癌自动图像分割和治疗反应评估的多任务深度学习
Int J Comput Assist Radiol Surg. 2025 Sep 3. doi: 10.1007/s11548-025-03484-0.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.原发性手术后晚期上皮性卵巢癌患者残留病灶对生存预后的影响。
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2.
4
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
5
Point-cloud segmentation with in-silico data augmentation for prostate cancer treatment.用于前列腺癌治疗的基于计算机模拟数据增强的点云分割
Med Phys. 2025 Apr 3. doi: 10.1002/mp.17815.
6
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
7
Neoadjuvant chemotherapy before surgery versus surgery followed by chemotherapy for initial treatment in advanced epithelial ovarian cancer.晚期上皮性卵巢癌初始治疗中,术前新辅助化疗与手术加化疗的比较。
Cochrane Database Syst Rev. 2025 Feb 10;2(2):CD005343. doi: 10.1002/14651858.CD005343.pub7.
8
Are Current Survival Prediction Tools Useful When Treating Subsequent Skeletal-related Events From Bone Metastases?当前的生存预测工具在治疗骨转移后的骨骼相关事件时有用吗?
Clin Orthop Relat Res. 2024 Sep 1;482(9):1710-1721. doi: 10.1097/CORR.0000000000003030. Epub 2024 Mar 22.
9
Taxane monotherapy regimens for the treatment of recurrent epithelial ovarian cancer.紫杉烷类单药治疗方案用于复发性上皮性卵巢癌。
Cochrane Database Syst Rev. 2022 Jul 12;7(7):CD008766. doi: 10.1002/14651858.CD008766.pub3.
10
Influence of early through late fusion on pancreas segmentation from imperfectly registered multimodal magnetic resonance imaging.早期至晚期融合对来自配准不完善的多模态磁共振成像的胰腺分割的影响。
J Med Imaging (Bellingham). 2025 Mar;12(2):024008. doi: 10.1117/1.JMI.12.2.024008. Epub 2025 Apr 26.

本文引用的文献

1
Deep learning-based segmentation of multisite disease in ovarian cancer.基于深度学习的卵巢癌多部位病变分割。
Eur Radiol Exp. 2023 Dec 7;7(1):77. doi: 10.1186/s41747-023-00388-z.
2
Integrated radiogenomics models predict response to neoadjuvant chemotherapy in high grade serous ovarian cancer.整合放射基因组学模型预测高级别浆液性卵巢癌对新辅助化疗的反应。
Nat Commun. 2023 Oct 24;14(1):6756. doi: 10.1038/s41467-023-41820-7.
3
Objective responses to first-line neoadjuvant carboplatin-paclitaxel regimens for ovarian, fallopian tube, or primary peritoneal carcinoma (ICON8): post-hoc exploratory analysis of a randomised, phase 3 trial.
一线新辅助卡铂-紫杉醇方案治疗卵巢、输卵管或原发性腹膜癌的客观反应(ICON8):一项随机、3 期试验的事后探索性分析。
Lancet Oncol. 2021 Feb;22(2):277-288. doi: 10.1016/S1470-2045(20)30591-X. Epub 2020 Dec 22.
4
Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer.新辅助化疗与初始肿瘤细胞减灭术用于 IIIC 或 IV 期卵巢癌。
N Engl J Med. 2010 Sep 2;363(10):943-53. doi: 10.1056/NEJMoa0908806.